Hyundai Mobis to Assist Marine Corps in Reducing Motion Sickness in Armored Vehicles

• MOU Signed with the Marine Corps for the Advancement of Motion Sickness Reduction Technology, Specialized for Harsh Conditions in Armored Amphibious Vehicles
• Real-time Monitoring and Analysis of Passenger Biometric Data; Stimulation of Visual, Auditory, and Tactile Senses to Alleviate Motion Sickness Symptoms
• Integration of Autonomous Driving and Cognitive Technologies; Developing Specialized Technologies Beyond Automotive for Maritime Transportation and Future Mobility Industries

SEOUL, South Korea, Dec. 28, 2023 /PRNewswire/ -- Hyundai Mobis (KRX 012330) has announced the implementation of its cutting-edge vehicle healthcare technology in the Marine Corps amphibious assault vehicles. This technology is expected to alleviate motion sickness for marines traversing rough terrains from sea to land, enhancing combat performance.

Hyundai Mobis announced that it has signed a Memorandum of Understanding (MOU) with the Republic of Korea Marine Corps for 'Cooperation in Motion Sickness Reduction Technology.'

Recently, global automakers have been accelerating the development of technologies to enhance passenger comfort. Last year, Hyundai Mobis developed the 'Smart Cabin Controller,' analyzing a driver's posture, heart rate, and brainwaves to prevent drowsiness, stress, and motion sickness. This collaboration with the Marine Corps is expected to further advance motion sickness reduction technology to help marines traverse challenging terrains and withstand other harsh conditions.

Importantly, this marks the first application of Hyundai Mobis's motion sickness reduction technology in the broader mobility sector beyond conventional vehicles. Its introduction is anticipated to expand into defense, maritime, and aviation transportation.

Motion sickness generally occurs when there is a discrepancy between what the eyes see and what the body feels regarding movement direction – for example, looking sideways in a moving vehicle while the body senses forward motion. This is also why seats facing the opposite direction on a train are less preferred.

Hyundai Mobis' motion sickness reduction technology integrates autonomous driving with passenger cognitive technologies. Especially the latter involves real-time monitoring of posture, heart rate, and brainwaves using sensors. Based on this biometric data, simulating the senses of sight, hearing, smell, and touch can minimize motion sickness. Hyundai Mobis confirmed that this technology can prevent motion sickness by up to 70% and reduce the symptoms by 40%.

Hyundai Mobis will provide the Marine Corps with an integrated motion sickness reduction solution tailored for harsh environments, combining hardware and software. The solution includes movement-analysis sensors, environmental perception sensors, and control solutions. It also features displays allowing passengers to easily view travel information (visual) and climate control modules that stabilize passengers with cool air (tactile).

Hyundai Mobis plans to operate this technology in amphibious assault vehicles and, in collaboration with the Marine Corps, gather key data by the first half of next year. The company aims to deploy it in combat training and systematically analyze motion sickness-inducing factors to enhance the technology's efficacy.

About Hyundai Mobis

Hyundai Mobis is the global no. 6 automotive supplier, headquartered in Seoul, Korea. Hyundai Mobis has outstanding expertise in sensors, sensor fusion in ECUs and software development for safety control. The company's products also include various components for electrification, brakes, chassis and suspension, steering, airbags, lighting, and automotive electronics. Hyundai Mobis operates its R&D headquarters in Korea, with four technology centers in the United States, Germany, China and India. For more information, please visit the website at http://www.mobis.co.kr/

Media Contact 
Choon Kee Hwang: [email protected]
Myong Sun Song: [email protected]

SOURCE Hyundai Mobis